Position in NUVL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$0
New position
Shares Held
50,000
first reported quarter
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Alberta Investment Management Corp holds $29,245,270 across 6 Biotechnology names. NUVL ranks #5 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
75,000 | $9,954,750 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
113,200 | $9,842,740 | |
| 3 | ABVX |
Abivax S.A.
|
65,000 | $8,661,900 | |
| 4 | ZURA |
Zura Bio Ltd
|
133,200 | $785,880 | |
| 5 | NUVL |
Nuvalent, Inc.
This page
|
50,000 | $0 | |
| 6 | VRXA |
Veraxa Biotech Holding AG
|
875,000 | $0 |
All Filings in NUVL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 50,000 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||